Summary
This 8-K filing from CVS Health Corporation (CVS) on March 13, 2018, primarily reports the results of a special meeting of its stockholders held on the same date. The key event was the stockholder approval of the issuance of CVS Health common stock in connection with the previously announced merger agreement with Aetna Inc. The overwhelming approval of this proposal is a significant step towards the closing of this transformative acquisition. Investors should note that the strong affirmative vote from CVS Health stockholders signals significant support for the strategic rationale behind the Aetna acquisition. This filing confirms that a critical hurdle has been cleared, moving the company closer to combining its pharmacy benefits and retail operations with Aetna's health insurance business. The company also announced the results via press release, which is incorporated by reference.
Key Highlights
- 1CVS Health stockholders overwhelmingly approved the issuance of CVS Health common stock for the acquisition of Aetna Inc.
- 2The special meeting held on March 13, 2018, saw a high turnout of shares, with a substantial majority voting in favor of the stock issuance proposal.
- 3The approval of the stock issuance is a key milestone in the pending merger between CVS Health and Aetna.
- 4A proposal to adjourn the special meeting was not called, as there were sufficient votes to approve the stock issuance.
- 5The company issued a press release on March 13, 2018, announcing the results of the stockholder vote, which is included as an exhibit.
- 6The filing emphasizes that this communication is not an offer to sell or a solicitation of an offer to buy securities.
- 7Investors are urged to read the definitive joint proxy statement/prospectus filed with the SEC for more detailed information on the transaction.